Raising the bar to ultradisciplinary collaborations in management of chronic thromboembolic pulmonary hypertension
Authors:
- Tankut AkayTATankut Akay
- Cihangir KaymazCKCihangir Kaymaz
- Ahmet Rüçhan AkarAAAhmet Rüçhan Akar
- Gökçen OrhanGOGökçen Orhan
- Mehmed YanartaşMYMehmed Yanartaş
- Bahadır GültekinBGBahadır Gültekin
- Mustafa ŞırlakMŞMustafa Şırlak
- Ümit KervanÜKÜmit Kervan
- Serpil Gezer TaşSTSerpil Gezer Taş
- Murat BiçerMBMurat Biçer
- Tahir YağdıTYTahir Yağdı
- Selim İsPirSISelim İsPir
Open Access
- 1 July 2021
- journal article
- review article
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 29 (3) , 417-431
Abstract
Chronic thromboembolic pulmonary hypertension is an underdiagnosed and potentially fatal subgroup of pulmonary hypertension, if left untreated. Clinical signs include exertional dyspnea and non-specific symptoms. Diagnosis requires multimodality imaging and heart catheterization. Pulmonary endarterectomy, an open heart surgery, is the gold standard treatment of choice in selected patients in specialized centers. Targeted medical therapy and balloon pulmonary angioplasty can be effective in high-risk patients with significant comorbidities, distal pulmonary vascular obstructions, or recurrent/persistent pulmonary hypertension after pulmonary endarterectomy. Currently, there is a limited number of data regarding novel coronavirus-2019 infection in patients with chronic thromboembolic pulmonary hypertension and the changing spectrum of the disease during the pandemic. Challenging times during this outbreak due to healthcare crisis and relatively higher case-fatality rates require convergence; that is an ultradisciplinary collaboration, which crosses disciplinary and sectorial boundaries to develop integrated knowledge and new paradigms. Management strategies for the "new normal" such as virtual care, preparedness for further threats, redesigned standards and working conditions, reevaluation of specific recommendations, and online collaborations for optimal decisions for chronic thromboembolic pulmonary hypertension patients may change the poor outcomes.Keywords
This publication has 80 references indexed in Scilit:
- Chronic thromboembolic pulmonary hypertension in pediatric patientsThe Journal of Thoracic and Cardiovascular Surgery, 2011
- Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary HypertensionJACC, 2008
- Successful Extracorporeal Membrane Oxygenation Support After Pulmonary ThromboendarterectomyThe Annals of Thoracic Surgery, 2008
- Ventilation-Perfusion Scintigraphy Is More Sensitive than Multidetector CTPA in Detecting Chronic Thromboembolic Pulmonary Disease as a Treatable Cause of Pulmonary HypertensionJournal of Nuclear Medicine, 2007
- Predictors of Outcome in Chronic Thromboembolic Pulmonary HypertensionCirculation, 2007
- Reverse right ventricular remodeling after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: Utility of magnetic resonance imaging to demonstrate restoration of the right ventricleThe Journal of Thoracic and Cardiovascular Surgery, 2007
- Venovenous Extracorporeal Life Support After Pulmonary Endarterectomy: Indications, Techniques, and OutcomesThe Annals of Thoracic Surgery, 2006
- Controversies, Uncertainties and Future Research on the Treatment of Chronic Thromboembolic Pulmonary HypertensionProceedings of the American Thoracic Society, 2006
- Outcomes of pulmonary endarterectomy for treatment of extreme thromboembolic pulmonary hypertensionThe Journal of Thoracic and Cardiovascular Surgery, 2006
- Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertensionThrombosis and Haemostasis, 2005